Peter H J van der Voort1, Rik T Gerritsen2, Andries J Bakker3, E Christiaan Boerma2, Michael A Kuiper2, Loek de Heide4. 1. Dept. of Intensive Care, Medical Centre Leeuwarden, P.O. Box 888, 8901 BR, Leeuwarden, The Netherlands. phjvdvoort@wxs.nl. 2. Dept. of Intensive Care, Medical Centre Leeuwarden, P.O. Box 888, 8901 BR, Leeuwarden, The Netherlands. 3. Dept. of Clinical Chemistry, Medical Centre Leeuwarden, Leeuwarden, The Netherlands. 4. Dept. of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Abstract
OBJECTIVE: To explore the relationship between cholesterol levels and the adrenal cortisol response to synacthen in critically ill patients. DESIGN: Prospective observational study. PATIENTS: Critically ill patients with multiple organ dysfunction syndrome (MODS) with possible adrenal dysfunction defined as unexplained hypotension, ongoing inotropic support, unexplained fever, unexplained hyponatraemia or a combination of these symptoms. MEASUREMENTS: HDL-cholesterol levels (HDL), total cholesterol levels (TC), and triglycerides (TG) before administration of synacthen. LDL-cholesterol was calculated using the Friedewald formula. Basal cortisol and response to 250 microg synacthen intravenously was measured. A cortisol rise of 0.25 micromol/l in a 30-min or 60-min blood sample after synacthen infusion was defined as a proper adrenal response. RESULTS: Patients with a proper response to synacthen showed higher HDL-cholesterol levels than patients without that response ( P=0.02). Severity of disease as measured by APACHE II or SOFA was not a confounder. LDL-cholesterol levels were extremely low in both responders and non-responders and were not associated with the absolute rise in cortisol. In linear and logistic regression analysis HDL-cholesterol was the sole predictor of cortisol response. CONCLUSIONS: Adrenal cortisol response to a "classic" 250-microg synacthen test relates in critically ill patients to HDL-cholesterol levels. LDL and TC levels did not show such a relation. These findings are in concordance with known biochemical pathways of cortisol production.
OBJECTIVE: To explore the relationship between cholesterol levels and the adrenal cortisol response to synacthen in critically illpatients. DESIGN: Prospective observational study. PATIENTS: Critically illpatients with multiple organ dysfunction syndrome (MODS) with possible adrenal dysfunction defined as unexplained hypotension, ongoing inotropic support, unexplained fever, unexplained hyponatraemia or a combination of these symptoms. MEASUREMENTS: HDL-cholesterol levels (HDL), total cholesterol levels (TC), and triglycerides (TG) before administration of synacthen. LDL-cholesterol was calculated using the Friedewald formula. Basal cortisol and response to 250 microg synacthen intravenously was measured. A cortisol rise of 0.25 micromol/l in a 30-min or 60-min blood sample after synacthen infusion was defined as a proper adrenal response. RESULTS:Patients with a proper response to synacthen showed higher HDL-cholesterol levels than patients without that response ( P=0.02). Severity of disease as measured by APACHE II or SOFA was not a confounder. LDL-cholesterol levels were extremely low in both responders and non-responders and were not associated with the absolute rise in cortisol. In linear and logistic regression analysis HDL-cholesterol was the sole predictor of cortisol response. CONCLUSIONS: Adrenal cortisol response to a "classic" 250-microg synacthen test relates in critically illpatients to HDL-cholesterol levels. LDL and TC levels did not show such a relation. These findings are in concordance with known biochemical pathways of cortisol production.
Authors: H J van Leeuwen; A P van Beek; G M Dallinga-Thie; J A van Strijp; J Verhoef; K P van Kessel Journal: Neth J Med Date: 2001-09 Impact factor: 1.422
Authors: Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2004-06-15 Impact factor: 17.440
Authors: Vladimír Hrabovský; Alice Mendlová; Zdeněk Zadák; Vladimír Bláha; Radomír Hyšpler; Alena Tichá; Zdeněk Svagera Journal: Wien Klin Wochenschr Date: 2012-11-20 Impact factor: 1.704
Authors: Andrea E Bochem; Adriaan G Holleboom; Johannes A Romijn; Menno Hoekstra; Geesje M Dallinga-Thie; Mahdi M Motazacker; G Kees Hovingh; Jan A Kuivenhoven; Erik S G Stroes Journal: J Lipid Res Date: 2013-03-19 Impact factor: 5.922